Description of Research Expertise
My research falls into three broad categories 1) development and translation of novel molecular imaging agents primarily PET tracers 2) imaging radiation treatment response include imaging biomarkers and radiogenomic analysis and 3) clinical trials in breast, gynecologic, and prostate cancers to improve therapeutic ratio. I work establish interdisciplinary collaborations with radiology, medical physics, and the clinical teams in medical and surgical oncology.
Selected Publications
N.Taunk: 18F-FluorThanatrace (18F-FTT) positron emission tomography (PET/CT) in prostate cancer measures in vivo PARP-1 expression and is associated with adverse clinicopathologic features. American Society of Clinical Oncology ; McCormick Place Convention Center in Chicago, Illinois. Poster presentation. (5030): 2022.
N.Taunk: Evaluation of in vivo PARP-1 Expression with 18F-FluorThanatrace (18F-FTT) Positron Emission Tomography (PET/CT) in Clinically Localized Prostate Cancer
Publication
Society Of Nuclear Medicine & Molecular Imaging. Vancouver, Canada. Oral Presentation. : 2022.
LaVigne A.W., Fields E.C., Gillespie E.F., Green W.R., Hughes R.T., Kahn J.M., Lally B.E., Mansy G.J., Remick J.S., Schutz A.N., Taunk N.K. and Corteville J.D.: Power of Pedaling: Physician Well-being as a Collaborative Effort in Social Media-based Cycling. Radiation Oncology Education Collaborative Study Group, Asynchronous Virtual Oral Presentation. : 2022.
N.Taunk: Preliminary results of a phase Ib/2 window of opportunity clinical trial (NCT04454528) assessing the effects of preoperative (preop) pembrolizumab +/- radiation in early-stage breast cancer (eBC) Society Of Surgical Oncology 2022, Dallas, Texas , oral presentation. : 2022.
Hathout L, Wang Y, Wang Q, Vergalasova I, Elshaikh MA, Dimitrova I, Damast S, Li JY, Fields EC, Beriwal S, Keller A, Kidd EA, Usoz M, Jolly S, Jaworski E, Leung EW, Donovan E, Taunk NK, Chino J, Natesan D, Russo AL, Lea JS, Albuquerque KV, Lee LJ: A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women With Stage IIIC Endometrial Cancer Int J Radiat Oncol Biol Phys 110 (5): 1423-1431,2021.
Hoffman DI, Santos PMG, Goldbach M, Keele LJ, Taunk NK, Bogen HS, Burkbauer L, Jankowitz RC, Fosnot J, Wu LC, Freedman GM, Tchou JC: ASO Visual Abstract: Immediate Breast Reconstruction for Inflammatory Breast Cancer-Trends in Use and Clinical Outcomes, 2004-2016 Ann Surg Oncol : 2021.
Taunk NK, Shah NK, Hubley E, Anamalayil S, Trotter JW, Li T: Virtual reality-based simulation improves gynecologic brachytherapy proficiency, engagement, and trainee self-confidence Brachytherapy 20 (4): 695-700,2021.
Hoffman DI, Santos PMG, Goldbach M, Keele LJ, Taunk NK, Bogen HS, Burkbauer L, Jankowitz RC, Fosnot J, Wu LC, Freedman GM, Tchou JC: Immediate Breast Reconstruction for Inflammatory Breast Cancer: Trends in Use and Clinical Outcomes 2004-2016 Ann Surg Oncol : 2021.
Mohiuddin JJ, Shanti RM, Alawi F, Chang BM, Marcel J, Taunk NK, Lukens JN: High-Dose-Rate Brachytherapy for Primary Treatment of Refractory Proliferative Verrucous Leukoplakia of the Hard Palate Cureus 13 (6): e15696,2021.
Provenzano D, Rao K, Cifter G, Taunk N, Fischer-Valuck B, Lin A, Sarfaraz M, Aghdam H, Ojong-Ntui M, Loew MH, Goyal S, Rao YJ: Adverse events of after-loading high dose rate brachytherapy reported to the United States Food and Drug Administration (FDA) Brachytherapy S1538-4721 (21): 00098-2,2021.
Academic Contact Information
Department of Radiation Oncology
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
Philadelphia,
PA
19104
Phone: 215-662-6515
Patient appointments: 800-789-7366